Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Finance
Clinical Trials
Professional Services
Cardiology
Biotechnology
Pharmaceutical
Health
Science
Oncology
First Quarter

More Like This

Business Wire logo

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

Business Wire logo

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

Business Wire logo

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

Business Wire logo

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights

Business Wire logo

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Business Wire logo

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire logo

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs

Business Wire logo

Prothena to Report First Quarter 2024 Financial Results on May 8

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us